Robert Andrew Douglas - 15 Feb 2023 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
15 Feb 2023
Net transactions value
-$320,250
Form type
4
Filing time
16 Feb 2023, 18:12:33 UTC
Previous filing
27 Feb 2023
Next filing
16 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $320,250 -1,500 -0.57% $213.50 261,445 15 Feb 2023 Douglas Family Trust F1, F2
holding RMD ResMed Common Stock 16,819 15 Feb 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes a transfer of shares between direct and indirect holdings on 2/8/2023.